Solo - R669-AD-1334
Laufzeit: 01.01.2015 - 31.12.2016
Kurzfassung
A Phase 3 confirmatory study investigating the efficacy and safety of dupilumab monotherpy administered to adult patients with moderate-to-severe atopic dermatitis
Laufzeit: 01.01.2015 - 31.12.2016
A Phase 3 confirmatory study investigating the efficacy and safety of dupilumab monotherpy administered to adult patients with moderate-to-severe atopic dermatitis
